DK200289D0 - Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et immunosuppresivt virksomt farmaceutisk praeparat - Google Patents

Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et immunosuppresivt virksomt farmaceutisk praeparat

Info

Publication number
DK200289D0
DK200289D0 DK200289A DK200289A DK200289D0 DK 200289 D0 DK200289 D0 DK 200289D0 DK 200289 A DK200289 A DK 200289A DK 200289 A DK200289 A DK 200289A DK 200289 D0 DK200289 D0 DK 200289D0
Authority
DK
Denmark
Prior art keywords
preparation
pharmaceutical
acid derivative
suitable salt
immunosuppressive effective
Prior art date
Application number
DK200289A
Other languages
English (en)
Other versions
DK200289A (da
DK170414B1 (da
Inventor
Neil Richard Ackerman
Bruce Donald Jaffee
Scott Edward Loveless
Russell Howard Neubauer
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of DK200289D0 publication Critical patent/DK200289D0/da
Publication of DK200289A publication Critical patent/DK200289A/da
Application granted granted Critical
Publication of DK170414B1 publication Critical patent/DK170414B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK200289A 1988-04-26 1989-04-25 Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af farmaceutiske præparater DK170414B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18624388 1988-04-26
US07/186,243 US4968701A (en) 1988-04-26 1988-04-26 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents

Publications (3)

Publication Number Publication Date
DK200289D0 true DK200289D0 (da) 1989-04-25
DK200289A DK200289A (da) 1989-10-27
DK170414B1 DK170414B1 (da) 1995-08-28

Family

ID=22684181

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200289A DK170414B1 (da) 1988-04-26 1989-04-25 Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af farmaceutiske præparater

Country Status (13)

Country Link
US (1) US4968701A (da)
EP (1) EP0339485B1 (da)
JP (1) JP2650757B2 (da)
KR (1) KR0134376B1 (da)
AT (1) ATE87480T1 (da)
CA (1) CA1333155C (da)
DE (1) DE68905642T2 (da)
DK (1) DK170414B1 (da)
IE (1) IE64760B1 (da)
IL (1) IL90055A (da)
MY (1) MY106038A (da)
PT (1) PT90363B (da)
ZA (1) ZA893087B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102883A (en) * 1989-10-31 1992-04-07 Du Pont Merck Pharmaceutical Company Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
US5204329A (en) * 1990-06-11 1993-04-20 Du Pont Merck Pharmaceutical Company Treatment of organ transplantation rejection
US5135934A (en) * 1990-07-06 1992-08-04 Du Pont Merck Pharmaceutical Company 3-phenyl-5,6-dihydrobenz(c) acridine-7-carboxylic acids and related compounds as immunosuppressive agents
MX9200299A (es) * 1991-02-07 1992-12-01 Roussel Uclaf Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
US6004979A (en) * 1991-02-07 1999-12-21 Hoechst Marion Roussel Nitrogenous bicycles
US6194376B1 (en) 1991-03-11 2001-02-27 Creative Biomolecules, Inc. Method for modulating inflammatory response comprising administering morphogen
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
US5409886A (en) * 1993-02-18 1995-04-25 Mitsui Toatsu Chemicals, Incorporated 3-pyrroline-2-one derivatives and herbicidal compositions containing same
US5428040A (en) * 1993-08-31 1995-06-27 The Du Pont Merck Pharmaceutical Company Carbocyclic fused-ring quinolinecarboxylic acids useful as immunosuppressive agents
US5578609A (en) * 1994-03-25 1996-11-26 The Dupont Merck Pharmaceutical Company 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
EP0830133A1 (en) * 1995-04-28 1998-03-25 Takeda Chemical Industries, Ltd. Therapeutic composition for arthritis
AU2896097A (en) * 1996-05-10 1997-12-05 Novartis Ag Use of brequinar and derivatives in chronic rejection of allografts and xenotransplantation
ES2173391T3 (es) * 1996-08-16 2002-10-16 Pfizer Derivados de 2-aminobenzazepina y su uso para el tratamiento de la inmunodepresion.
AU757059B2 (en) 1997-06-19 2003-01-30 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
AU2108099A (en) * 1998-01-30 1999-08-16 Procept, Inc. Immunosuppressive agents
DK2160950T3 (da) 2004-09-27 2015-06-08 Novozymes As Enzymgranuler
TN2016000197A1 (en) 2013-11-22 2017-10-06 Genzyme Corp Novel methods for treating neurodegenerative diseases.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6592M (da) * 1967-10-31 1968-12-30
GB1334705A (en) * 1970-06-19 1973-10-24 Ici Ltd Pharmaceutical compositions containing kynurenic acid derivatives
CH576445A5 (da) * 1972-03-10 1976-06-15 Ciba Geigy Ag
US4407803A (en) * 1981-08-17 1983-10-04 Abbott Laboratories Antiinflammatory 1-(quinolinyl)-2-pyrazoline derivatives
US4680299A (en) * 1984-04-30 1987-07-14 E.I. Du Pont De Nemours And Company 2-phenyl-4-quinolinecarboxylic acids and pharmaceutical compositions thereof
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4847381A (en) * 1987-08-31 1989-07-11 American Cyanamid Company 2-Phenyl-4-quinoline carboxylic acids

Also Published As

Publication number Publication date
PT90363B (pt) 1994-08-31
KR900016137A (ko) 1990-11-12
DK200289A (da) 1989-10-27
PT90363A (pt) 1989-11-10
IE891328L (en) 1989-10-26
EP0339485B1 (en) 1993-03-31
IL90055A (en) 1993-05-13
ZA893087B (en) 1990-12-28
DE68905642D1 (de) 1993-05-06
CA1333155C (en) 1994-11-22
MY106038A (en) 1994-03-31
DK170414B1 (da) 1995-08-28
ATE87480T1 (de) 1993-04-15
AU628045B2 (en) 1992-09-10
DE68905642T2 (de) 1993-08-12
KR0134376B1 (ko) 1998-04-21
AU3332189A (en) 1989-11-02
IL90055A0 (en) 1989-12-15
JPH01313428A (ja) 1989-12-18
IE64760B1 (en) 1995-09-06
JP2650757B2 (ja) 1997-09-03
US4968701A (en) 1990-11-06
EP0339485A1 (en) 1989-11-02

Similar Documents

Publication Publication Date Title
DK200289D0 (da) Anvendelse af et 4-quinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et immunosuppresivt virksomt farmaceutisk praeparat
FI883249A (fi) Menetelmä terapeuttisesti käyttökelpoisten 3-desmetyylimevalonihappojohdannaisten valmistamiseksi
DK653688D0 (da) Stabiliserede laegemiddelaktive forbindelser, fremgangsmaade til deres frmstilling samt stabile laegemiddelpraeparater
PT87474A (pt) Process for the preparation of pharmaceutical compounds which contain ester 1-acetoxi-ethylic of cefuroxime
ATE50255T1 (de) Substituierte 9-fluor-3-methyl-7-oxo-2,3-dihydro7h-pyrido(1,2,3-de>(1,4>benzoxazin-6-carbonsaeur ; substituierte 5-amino-6-fluor-1,4-dihydro-4-oxochinolin-3-carbons|ure; substituierte 5-amino-6fluor-1,4-dihydro-4-oxo-1,8-naphthyridin-3- carbonsaeure; ihre derivate; diese enthaltende pharmazeutische zubereitungen und verfahren
SE7903186L (sv) Cerebralverksamt medel
NO883506L (no) Fremgangsmaate for fremstilling av foretrede polyoksyalkylenderivater.
DK644388D0 (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
RU93045145A (ru) Замещенные производные циклогексана и их применение для лечения заболеваний, содержащее их лекарственное средство
DK199789D0 (da) Anvendelse af et phenylquinolincarboxylsyrederivat eller et farmaceutisk egnet salt deraf til fremstilling af et topisk farmaceutisk praeparat til behandling af hud- og/eller slimepithelsygdomme
NO883074D0 (no) Fremgangsmaate til fremstilling av 3-desmetyl-4-fluor-mevalonsyrederivater.
NO912545D0 (no) Nye 3,3'-ditobis (propionsyrer) og estere derav samt fremgangsmaate for dens fremstilling.
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
ATE86974T1 (de) (2-cyan-2-oximinoacetyl)-aminosaeure-derivate.
ITMI920539A0 (it) Procedimento per la separazione dell'acido ftalimmido perossicaproico da soluzioni di solventi organici
PT87743A (pt) Process for the preparation of pyrimidine derivatives and of insecticide and acaricide compounds which contain them
DK0440100T3 (da) Anvendelse af et galdesyresalt og et lipid
DK357786D0 (da) Aromatiske estere af 1,4,5,6,7,8-hexahydro-2-alkyl-4-aryl-5-oxo-1,7-naphthyridin-3-carboxylsyre eller farmaceutiske acceptable salte deraf
DK163432C (da) Analogifremgangsmaade til fremstilling af oe1,2,4aatriazolo-oe4,3-aaaquinoxalin-4-amin-derivater eller farmaceutisk acceptable syreadditionssalte deraf
IT8521824A0 (it) Procedimento per la preparazione dell'estere metilico di alfa-l.-aspartil-l-fenilalanina apartire da anidride n-fenacetil-l-aspartica edl-fenilalanina metil estere.
IT8719949A0 (it) Composizioni farmaceutiche adattivita' immunomodulante.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed